Saamya Biotech (India) Financials

BSE: 532905

₹1.97

₹-0.10 (-4.83%)

As on 13-Aug-2018IST

Market cap

₹5 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Operating Revenue	--	14.40	28.77	13.36	2.98	23.07
Total Income	--	14.51	28.80	13.37	2.98	23.73
Total Expenditure	0.02	14.53	28.53	13.08	3.29	22.49
EBITDA	-0.02	-0.13	0.24	0.28	-0.31	0.58
Depreciation	--	0.92	1.00	0.12	0.07	0.07
EBIT	-0.02	-1.05	-0.76	0.17	-0.38	0.51
Interest	--	0.00	0.00	0.02	0.03	0.81
Other Income	--	0.11	0.03	0.00	--	0.66
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.02	-0.94	-0.73	0.15	-0.41	0.35
Provision for Tax	--	-0.50	-0.05	0.06	-0.01	0.08
Profit after Tax	-0.02	-0.44	-0.68	0.10	-0.40	0.28

Liabilities (₹ Cr)	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Shareholder's Funds	-13.42	28.26	28.70	29.38	33.66	33.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.24	2.72	3.61	4.46	0.35	0.39
Current Liabilities	48.05	47.83	40.61	10.74	19.12	16.72
Total Liabilities	37.87	79.33	72.93	44.57	53.13	50.69

Assets (₹ Cr)	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Non-Current Assets	18.44	27.95	29.07	30.21	30.92	30.76
Current Assets	19.27	50.85	43.83	14.35	22.19	19.91
Total Assets	37.88	79.33	72.93	44.57	53.13	50.69
Total Debt*	--	3.24	3.63	4.43	0.35	0.38
Net Current Assets	-28.77	3.02	3.23	3.61	3.07	3.19
Contingent Liabilities	--	0.20	0.20	--	--	--

Cashflow (₹ Cr)	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Cash From Operating Activities	--	0.08	0.62	-0.22	-0.19	-1.01
Cash Flow from Investing Activities	--	0.31	0.17	0.51	-0.29	-0.51
Cash from Financing Activities	--	-0.39	-0.80	-0.28	0.45	1.52
Net Cash Inflow / Outflow	--	0.00	0.00	0.01	-0.03	0.01

Financials Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Adjusted EPS (₹)	-0.01	-0.18	-0.27	0.04	-0.16	0.11
Cash EPS (₹)	--	0.19	0.13	0.09	-0.13	0.14
Adjusted Book Value (₹)	--	11.35	11.53	11.80	11.76	11.92
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.03	0.25	-0.09	-0.08	-0.40
Free Cash Flow per Share (₹)	--	0.28	0.28	-4.39	-0.10	-0.54

Profitability Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
ROCE (%)	--	-2.93	-2.22	0.50	-1.11	3.54
ROE (%)	--	-1.55	-2.34	0.33	-1.36	1.05
ROA (%)	-0.05	-0.58	-1.16	0.20	-0.77	0.62
EBIT Margin (%)	--	-7.27	-2.64	1.24	-12.69	2.19
Net Margin (%)	--	-3.04	-2.36	0.71	-13.41	1.17
Cash Profit Margin (%)	--	3.15	1.05	1.52	-11.01	1.51

Growth Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Revenue Growth (%)	--	-49.94	115.31	347.99	-87.07	41.65
EBIT Growth (%)	35.48	-38.00	-559.49	143.65	-174.83	118.60
Net Profit Growth (%)	35.48	35.01	-812.06	123.84	-243.51	215.90
EPS Growth (%)	35.48	35.01	-812.07	123.84	-243.48	193.19
Book Value Growth (%)	--	-1.53	-2.30	0.34	-1.34	27.83

Valuation Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Price / Earnings	--	--	--	29.76	--	29.55
Price / Book Value	0.17	0.37	0.24	0.10	0.13	0.28
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-406.24	-773.68	39.62	25.15	-13.35	6.91
Close Price (₹)	--	4.23	2.75	1.14	1.51	3.31
High Price (₹)	--	9.09	6.25	2.82	3.94	8.49
Low Price (₹)	--	2.20	0.98	1.05	1.15	2.90
Market Cap (₹ Cr)	4.90	10.53	6.84	2.84	3.76	8.24

Solvency Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Debt to Equity	-0.24	0.11	0.13	0.15	0.01	0.01
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.40	1.06	1.08	1.34	1.16	1.19
Quick Ratio	0.40	1.06	1.08	1.34	1.16	1.19
Interest Coverage	--	-399.67	-1,153.53	9.89	-13.49	1.43

Operating Efficiency Ratios	TTM	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07
Debtors to sales (%)	--	348.41	150.07	98.53	704.47	79.59
Asset Turnover	--	0.20	0.51	0.29	0.06	0.51
Receivable days	--	1,126.58	340.37	444.56	2,409.01	207.89
Inventory Days	--	--	--	--	--	--
Payable days	--	1,100.53	320.65	409.85	2,246.25	198.83
Cash Conversion Cycle	--	26.06	19.71	34.71	162.76	9.06

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.